563 results on '"van Zanten S"'
Search Results
2. Prognostic factors among patients with brain metastases from cancer of unknown primary site
3. A112 THE EDMONTON PANCREATICOBILIARY INFLAMMATION AND CANCER (EPIC) PROGRAM – A NEW MULTIDISCIPLINARY COORDINATION OF CARE INITIATIVE
4. Diagnostic approach at specialized syncope units in the netherlands: a cross-sectional, nationwide survey
5. Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020)
6. A239 PATIENT OUTCOMES AFTER ENDOSCOPIC STENT INSERTION FOR MALIGNANT BILIARY OBSTRUCTION: A QUALITY ASSURANCE STUDY
7. What are the global response rates to Helicobacter pylori eradication therapy?
8. Dyspepsia is no indication for Helicobacter pylori eradication
9. Peptic ulcer disease — the transitional zones are important
10. What is the role of bismuth in Helicobacter pylori antimicrobial resistance?
11. The Role of Helicobacter pylori Infection in Duodenal and Gastric Ulcer
12. Brain metastases in patients with cancer of an unknown primary tumour in the Netherlands, A status update.
13. Prognostic factors among patients with brain metastases from cancer of unknown primary site
14. H. pylori and NSAIDs: a meta-analysis on interactions of acute gastroduodenal injury, gastric and duodenal ulcers and upper gastrointestinal symptoms
15. Single and Multichannel Magnetic Field Measurements of Gastrointestinal Activity in the Pre- and Post-Prandial States
16. Measuring Symptoms in Helicobacter pylori-Associated Gastritis and Non-Ulcer Dyspepsia
17. A226 INCIDENTAL FINDING OF A LARGE GASTRIC VARIX ASSOCIATED WITH NEONATAL UMBILICAL VEIN CANALIZATION
18. A111 THE CANADA-GLOBAL RATING SCALE: USE OF AN INNOVATION LEARNING COLLABORATIVE METHODOLOGY TO GUIDE PROVINCIAL IMPLEMENTATION IN ALBERTA
19. A79 PROVINCIAL DATA IN ALBERTA REVEAL A CLEAR NEED TO ADDRESS OVERPRESCRIBING OF PROTON PUMP INHIBITORS
20. A76 CLINICAL OUTCOMES, HEALTHCARE UTILIZATION AND COSTS AVOIDED WHEN ROUTINE GASTROENTEROLOGY REFERRALS ARE MANAGED IN PRIMARY CARE SUPPORTED BY CO-DEVELOPED CLINICAL CARE PATHWAYS
21. A142 TRENDS IN HELICOBACTER PYLORI TREATMENT AND CURE IN EDMONTON: 2015–2020
22. COMMUNITY-BASED RESEARCH ON H. PYLORI INFECTION IN THE CANADIAN ARCTIC: HISTOPATHOLOGICAL FINDINGS SHOW A HIGH PREVALENCE OF SEVERE GASTRITIS: Abstract no.: P04.02
23. Meta-analysis: oral or enteral nutritional supplementation in cirrhosis
24. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease
25. Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents
26. Risk of Colorectal Carcinoma in Post-Liver Transplant Patients: A Systematic Review and Meta-analysis
27. Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices
28. Endoscopic and Histopathologic Characteristics of H. pylori Infection in a Canadian Arctic Hamlet: Abstract no.: W1.8
29. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis
30. Clinical trial design in adult reflux disease: a methodological workshop
31. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeksʼ treatment with esomeprazole: a randomized, placebo-controlled study
32. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?
33. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects
34. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire
35. Meta-analysis: Helicobacter pylori eradication treatment efficacy in children
36. Systematic review of the use of patientsʼ own medications in acute care institutions
37. The prevalence of Barrettʼs oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy
38. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials
39. Validation of a symptom diary for patients with gastro-oesophageal reflux disease
40. Comprehension and awareness of symptoms in women with dyspepsia
41. The changing epidemiology of hepatocellular carcinoma in Canada
42. The efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients
43. Heartburn-dominant, uninvestigated dyspepsia: a comparison of ‘PPI-start’ and ‘H2-RA-start’ management strategies in primary care – the CADET-HR Study
44. Use of oesophageal dilatation in clinical practice
45. Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland
46. the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies
47. Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
48. The methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia
49. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia
50. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.